Revenue Growth
ZS achieved a 25.9% increase in revenue year-over-year, driven by strong demand for its cybersecurity solutions.
Source: 10-Q Income Statement
Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
ZS reported a significant revenue increase in Q2 FY2026, but faced widening net losses due to rising costs and R&D expenses.
Revenue
$815.75M
+25.91% YoY
EPS (Diluted)
-$0.21
-320.00% YoY
Gross Margin
76.6%
-0.5 pts YoY
Operating Income
-$51.77M
-28.98% YoY
Source: SEC XBRL
Zscaler (ZS) reported Q2 FY2026 revenue of $815.75M, up 25.9% year over year. Operating margin was -6.3%, against -6.2% a year earlier. ZS's fiscal Q2 FY2026 corresponds to calendar Q1 2026.
Last 4 quarters: 4 beats
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026 | 1.08 | 1.04 | Beat +4.0% |
| Mar 2026This filing | 1.01 | 0.92 | Beat +9.3% |
| Dec 2025 | 0.96 | 0.89 | Beat +8.4% |
| Sep 2025 | 0.89 | 0.82 | Beat +8.2% |
Adjusted (non-GAAP) EPS of $1.01 versus the $0.92 analyst consensus — a +9.3% beat for Mar 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was -$0.21.
Compiled by AI from this SEC filing
ZS achieved a 25.9% increase in revenue year-over-year, driven by strong demand for its cybersecurity solutions.
Source: 10-Q Income Statement
Research and development expenses rose by 34.1%, reflecting the company's investment in innovation and product development.
Source: 10-Q Income Statement
Operating income declined by 29.0% year-over-year, indicating challenges in managing operational costs.
Source: 10-Q Income Statement
Compiled by AI from this SEC filing · 2 high, 1 medium, 0 low
The significant increase in R&D expenses could impact profitability if new products do not generate expected returns.
Source: 10-Q Income Statement
The substantial negative cash flow from investing activities suggests high capital expenditure, which may strain liquidity.
Source: 10-Q Cash Flow Statement
A 31.6% decrease in cash and equivalents raises concerns about the company's ability to meet short-term obligations.
Source: 10-Q Balance Sheet
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue $M | 815.75 $M | 647.90 $M | +25.91% |
Cost of Revenue $M | 191.26 $M | 148.50 $M | +28.80% |
Gross Profit $M | 624.49 $M | 499.40 $M | +25.05% |
Operating Income $M | -51.77 $M | -40.14 $M | -28.98% |
Net Income $M | -34.31 $M | -7.72 $M | -344.23% |
EPS (Basic) $ | -0.21 $ | -0.05 $ | -320.00% |
EPS (Diluted) $ | -0.21 $ | -0.05 $ | -320.00% |
R&D Expense $M | 229.14 $M | 170.86 $M | +34.11% |
Answers draw on this SEC filing and the data on this page